Researchers are working to determine how and which cannabis products can help those suffering from chronic pain or serious illness. But science is having a hard time keeping up with the booming market.
Academic rigour, journalistic flair
Articles on CBD
Displaying 1 - 20 of 42 articles
A THC-like substance that occurs naturally in humans and other vertebrates helps maintain immunity, memory, nerve function and more – and research suggests a lack of it can harm health.
CBD isn’t a miracle cure for everything that ails a person – but science shows that it has the potential to help treat a number of health conditions.
Our study also examined the way media coverage may affect a patient’s expectations of cannabis in treating pain.
Studies suggest that marijuana and CBD use might help relieve chronic pain while also reducing a patient’s need for opioids.
A survey of more than 2,000 people as Melbourne reopened after COVID lockdowns shows the pandemic and digital technology have made the city less a place of work, more a place to visit now and then.
Policy-makers and stakeholders in Canada should re-examine CBD policies and ensure they are protecting, rather than confusing, consumers.
Scholars weigh in on the known and unknown about marijuana and its incarnations.
A growing body of research points to the body’s natural cannabinoid system as the primary driver behind the runner’s high – and the mental health boost and stress relief following exercise.
Some psychedelic drugs – paired with therapy – hold great potential for helping sufferers of PTSD, depression and other mental health disorders.
Cannabis labelling is often misleading. Labelling cannabis products with quantities of key compounds will help consumers make informed decisions.
Although a recent review found a lack of evidence to support these products, this doesn’t mean cannabis can’t help some people with sleep. We need better research.
Hemp, CBD and marijuana are all forms of cannabis – but they are different in significant ways, from form and legality to their potential uses as treatment for various health conditions.
World-leading university campus developments overseas call into question plans for CBD-based campuses in Australia. They might be good for CBD development, but what about the universities themselves?
Out of the 400 plus chemical compounds in the cannabis plant, CBD and THC are only the most well-known, and researched, cannabinoids.
Instead of free parking, our post-COVID CBDs need a big vision to become attractive destinations that aren’t car-friendly at the expense of being people-friendly.
The jury’s still out on whether or not CBD relieves stress and anxiety.
It’s important patients taking prescribed medicinal cannabis products are not unduly penalised. But it’s equally important we minimise the chance drivers put themselves or other road users at risk.
CBD retailers were already struggling before the pandemic. The contrast in fortunes with suburban retail activity is stark, and there are good reasons to think the shift could be permanent.
City by city, the data on CBD visitors vary with the severity of COVID-19 outbreaks and restrictions. But none of the CBDs has recovered former activity levels, and some might never fully recover.
Job Board
-
Head of School, Humanities
-
Research Officer - Structural Biology of E3 Ubiquitin Ligases
-
Policy and Research Project Manager
-
Lecturer in Linguistics and Applied Linguistics
-
Senior Lecturer/ Associate Professor, Economics
Top contributors
-
Professor of Pharmacy Practice, University of Connecticut
-
Assistant Professor of Psychiatry and Behavioral Neurosciences, Wayne State University
-
Professor of Marketing and Consumer Behaviour, Queensland University of Technology
-
Associate Professor & Programme co-ordinator (Masters of Public Policy), The University of Western Australia
-
Honorary Fellow, Department of Health Sciences, University of York
-
Professor of Pharmacy Practice, Drake University
-
Professor and Chair of Pharmacodynamics, University of Florida
-
Assistant Professor of Pharmacodynamics, University of Florida
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Adjunct professor of architecture, University of Adelaide
-
Senior Lecturer in Urban Planning & Design, Monash University
-
Professor of Architecture and Urban Design, The University of Melbourne
-
Louise Grimmer is a Friend of The Conversation.
Senior Lecturer in Retail Marketing, University of Tasmania
-
Director, Southern Cross Plant Science, Southern Cross University
